You are here

  • Home
  • Online First
  • Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby et al

Article info

Article menu

Download PDFPDF

Correspondence
Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby et al

Authors

  • Maya H Buch Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UKNIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Andrew Melville Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UKNIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Dennis G McGonagle Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UKNIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Maya H Buch, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS2 9JT, UK; m.buch{at}leeds.ac.uk
View Full Text

Citation

Buch MH, Melville A, McGonagle DG
Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby et al
Annals of the Rheumatic Diseases Published Online First: 13 July 2019. doi: 10.1136/annrheumdis-2019-215881

Publication history

  • Received June 12, 2019
  • Accepted June 17, 2019
  • First published July 13, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.